Modelos europeos de telemedicina, como el servicio finlandés Medilux, permiten realizar consultas médicas online mediante un cuestionario clínico, sin acudir a una consulta presencial.

Bifurcations: A Long Return Journey

When it looked like the simplest techniques reach the best outcomes, along came the DK Crush studies. Indeed, after the COVIS III results in bifurcations, it appeared we had started to retrace our steps back to the foundation. 

DKCRUSH-V: El tronco de la coronaria izquierda no es una bifurcación más

The purpose of this study was to compare long term outcomes of the remarkably simple 1-stent strategy to the main vessel (MV) with simple crossover alone vs. an additional side branch (SB) opening procedure with a second guidewire finalized with a kissing balloon.

Patients undergoing coronary PCI to a bifurcation (including left main) with the single stent strategy were included in this registry. 

2,194 patients were divided into the simple crossover–alone group (n=1.685, 76.8%) and the SB-opening group (n=509, 23.2%). Target lesion failure rate (a composite of cardiac death, target vessel myocardial infarction, and target lesion repeat revascularization) was assessed at a 5-year followup. 

The angiographic characteristics of patients in the SB-opening group with kissing balloon were more severe, even though lumen diameter resulted larger in this group. 

After 5 years, target lesion failure rate was similar between groups (7% vs 6.7%; p=0.947). 


Read also: A Headache for Cardiologists: Ischemia with Non-Obstructive Disease.


This was also true for the subgroup with left main lesion (9.5% vs. 11.3%; p=0.442) and lesions classified as Medina 1.1.1, 1.0.1 and 0.1.1 (5.3% vs. 7.8%; p=0.362). The latter are normally called true bifurcations. 

Conclusion

The remarkably simple 1-stent strategy to the main vessel with simple crossover alone showed long term comparable results to those obtained with an additional side branch opening procedure with a second guidewire finalized with a kissing balloon. 

j-jacasi-2021-04-002

Original title: 5-Year Outcome of Simple Crossover Stenting in Coronary Bifurcation Lesions Compared With Side Branch Opening. COBIS III 

Reference: Cheol Hyun Lee et al. JACC: Asia 2021;1:53–64.https://doi.org/10.1016/j.jacasi.2021.04.002


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

EuroPCR 2026 | 10-Year Left Main PCI: When Survival Is Similar, Should the Less Invasive Strategy Prevail?

The primary goal of revascularization in left main coronary artery disease (LMCA) is to improve survival. However, debate continues regarding whether, in anatomically suitable...

EuroPCR 2026 | TAVI and Coronary Artery Disease: FFR-Guided PCI Showed Better Outcomes Than an Angiography-Guided Strategy

In patients undergoing TAVI, the concomitant presence of coronary artery disease continues to generate debate: whether coronary lesions should be treated before, during, or...

EuroPCR 2026 | Evolocumab Reduces Cardiovascular Events in Patients With Prior PCI Without Previous Myocardial Infarction: VESALIUS-CV Results

This presentation, delivered by Dr. Brian A. Bergmark and colleagues at EuroPCR 2026, detailed the results of the VESALIUS-CV trial, focusing specifically on the...

EuroPCR 2026 | Is It Safe to Stop Aspirin After One Month in MI Patients Undergoing PCI? TARGET-FIRST Analysis

This is a summary of the post-hoc analysis of the TARGET-FIRST study, presented by Dr. Giuseppe Tarantini at EuroPCR 2026, evaluating early aspirin discontinuation...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

EuroPCR 2026 | MELA Registry: Myval Showed Lower Aortic Regurgitation Rates in Patients With Large Aortic Annuli

This presentation, delivered by Dr. Salvatore Giordano at EuroPCR 2026, detailed the results of the MELA Registry, a multicenter study comparing the performance of...

EuroPCR 2026 | LANDMARK Trial: Two-Year Results Showed Comparable Efficacy Between Myval and Contemporary TAVI Valves

The LANDMARK trial presentation, delivered by Prof. Patrick W. Serruys at EuroPCR 2026, detailed the two-year clinical outcomes of contemporary transcatheter aortic valve implantation...

EuroPCR 2026 | 10-Year Left Main PCI: When Survival Is Similar, Should the Less Invasive Strategy Prevail?

The primary goal of revascularization in left main coronary artery disease (LMCA) is to improve survival. However, debate continues regarding whether, in anatomically suitable...